5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5 Ubunyulu > 99.0% (GC) Palbociclib Intermediate Factory
I-Ruifu Chemical Supply Palbociclib Related Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
I-5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7 (8H)-enye CAS 1016636-76-2
I-2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-enye CAS 1013916-37-4
Igama leMchiza | 5-Bromo-2,4-Dichloropyrimidine |
Inombolo yeCAS | 36082-50-5 |
Inombolo yeCAT | RF-PI1852 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C4HBRCl2N2 |
Ubunzima beMolekyuli | 227.87 |
Indawo yokubilisa | 128℃/15 mmHg (lit.) |
Ukuxinana | 1.781 g/mL ku-25℃ (lit.) |
Refractive Index | n20/D 1.603 (lit.) |
Ukunyibilika | Inyibilika kwiMethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | AbunaMbala ukuya kuLwelo oluKhanyayo |
Ubunyulu / Indlela yokuHlalutya | >99.0% (GC) |
Indawo yokunyibilika | 29.0 ~ 30.0℃ |
Amanzi (nguKarl Fischer) | <0.50% |
2,4-Dichloropyrimidine | <0.50% (GC) |
Ubuninzi bokungacoceki komntu omnye | <0.50% (GC) |
Ukungcola ngokupheleleyo | <1.00% |
I-1 H NMR Spectrum | Ukungqinelana Nolwakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi wePalbociclib (CAS: 571190-30-2) |
Iphakheji: Ibhotile eneFluorinated, 25kg/Drum, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-5-Bromo-2,4-Dichloropyrimidine (i-CAS: 36082-50-5) ingaqeshwa njenge-reagent yokuqala yokudibanisa i-allosteric modulators emihle ye-GABAB receptors (i-drug-like class of compounds) kunye ne-pyridinepyrimidine analogs.I-5-Bromo-2,4-Dichloropyrimidine ingasetyenziselwa njengendawo ephakathi yePalbociclib (CAS: 571190-30-2).I-Palbociclib (ekwaziwa ngokuba yi-compound number PD-0332991) lichiza lovavanyo lonyango lomhlaza wamabele eliphuhliswa yiPfizer.I-Palbociclib yi-inhibitor ekhethiweyo ye-cyclin-dependent kinases CDK4 kunye ne-CDK6.